Latest / Stock Movers / Stitch Fix Earnings; Everpure Soars; Viking Therapeutics Falls
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios. Podcasts. Radio.
- 0:06Speaker 2: News.
- 0:08Speaker 1: The Stock Movers Report. Your roundup of companies making moves
- 0:12Speaker 1: in the stock market. Harnessing the power of Bloomberg data.
- 0:16Speaker 3: Let's take a look at some of the stocks on
- 0:18Speaker 3: the move here as we see equity markets pull back
- 0:20Speaker 3: on this Thursday. Judy LeGru is here with us. She's
- 0:23Speaker 3: a Bloomberg News equities reporter, and she's got three stocks
- 0:26Speaker 3: on her radar list.
- 0:27Speaker 1: What are you watching?
- 0:28Speaker 2: That's right. We are keeping it cute over here. We're
- 0:31Speaker 2: starting with Stitch Fix, ticker SFIX. Shares are plummeting as
- 0:36Speaker 2: much as 25% in trading today, and shares are on
- 0:39Speaker 2: track to reach their lowest price in nearly two and
- 0:42Speaker 2: a half years. And this is coming as the company
- 0:46Speaker 2: announced mixed fourth quarter results and gave a weaker than
- 0:49Speaker 2: expected outlook for the full year. And Mizzou analysts wrote
- 0:54Speaker 2: this morning that these results really represent, quote, a step
- 0:57Speaker 2: back for the company, and that as a small player
- 1:01Speaker 2: in their space, they're uniquely... exposed to consumer strain and
- 1:05Speaker 2: a complicated macro backdrop. So they really have doubts about
- 1:09Speaker 2: the company's turnaround as a result.
- 1:10Speaker 1: Of these results.
- 1:13Speaker 3: All right.
- 1:14Speaker 1: We got EverPure.
- 1:16Speaker 2: EverPure, that's right. The data storage company, ticker P.
- 1:20Speaker 1: How did they get that ticker?
- 1:21Speaker 3: As a banker, I used to fight over these things
- 1:23Speaker 3: and argue about which tickers my companies were using.
- 1:25Speaker 2: That's a story in and of itself, I would say. Yeah, yeah.
- 1:28Speaker 2: Shares are soaring as much as 20%, and they are
- 1:31Speaker 2: on track to reach their all-time high price. And this
- 1:35Speaker 2: is since the company went public 11 years ago. Shares
- 1:39Speaker 2: have nearly doubled year-to-date, and all of this is coming
- 1:41Speaker 2: after the company announced a revenue forecast for 2028 that
- 1:45Speaker 2: exceeded Wall Street estimates. They said that revenue growth would
- 1:49Speaker 2: ramp up due to booming demand for AI and opportunities
- 1:53Speaker 2: in the hyperscaler business. Bank of America analysts wrote that
- 1:57Speaker 2: EverPure is, quote, an idiosyncratic opportunity for an accelerating growth
- 2:02Speaker 2: story and sees about 25% growth in the core business
- 2:06Speaker 2: and $ 1. 6 billion in implied new business for EverPure.
- 2:10Speaker 1: Right.
- 2:11Speaker 3: And the last stock you're watching?
- 2:13Speaker 2: That's right. Viking Therapeutics, ticker VKTX. Shares are falling as
- 2:18Speaker 2: much as 16%. And those shares are on track for
- 2:21Speaker 2: their worst day since August of last year. Now, when
- 2:25Speaker 2: I looked at this, I thought, what goes up must
- 2:27Speaker 2: come down. The stock was on a three-day winning streak
- 2:31Speaker 2: all week. They've been up nearly 40% since Monday. And
- 2:34Speaker 2: all this movement today is coming after the biopharmaceuticals company
- 2:38Speaker 2: announced an approximately $ 500 million common stock offering and convertible
- 2:43Speaker 2: debt offering, which they say they'll use to develop their
- 2:45Speaker 2: injections and oral medication for GLP-1 weight loss maintenance.
- 2:51Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with
- 2:55Speaker 1: us throughout the day for the latest roundup of companies
- 2:57Speaker 1: making news on Wall Street. And for the latest market-moving headlines,
- 3:02Speaker 1: listen to Bloomberg Radio live. Catch us on YouTube, Bloomberg.com,
- 3:06Speaker 1: and on Apple CarPlay and Android Auto with the Bloomberg
- 3:09Speaker 1: Business app.